North China Pharmaceutical Co Ltd
SSE:600812
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is North China Pharmaceutical Co Ltd's stock price target?
Not Available
North China Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is North China Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
7%
For the last 13 years the compound annual growth rate for North China Pharmaceutical Co Ltd's revenue is -2%. The projected CAGR for the next 4 years is 7%.
What is North China Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
11%
For the last 13 years the compound annual growth rate for North China Pharmaceutical Co Ltd's net income is -1%. The projected CAGR for the next 4 years is 11%.